Skip to content
Trial Eligibility
Menu

Prostate Cancer Clinical Trials near Cleveland, OH

42 studies for Prostate Cancer are recruiting at 74 sites within 50 miles of Cleveland, Ohio, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Prostate Cancer trials in the US or all trials near Cleveland.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Prostate Cancer studies enrolling near Cleveland

Showing 42 studies, nearest first.
  1. Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

    NCT05946213

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Case Western Reserve University (Cleveland, OH); Cleveland Clinic Cancer Center/Fairview Hospital (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    15 sites within 50 mi
  2. Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

    NCT06592924

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: Case Western Reserve University (Cleveland, OH); Cleveland Clinic Cancer Center/Fairview Hospital (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    11 sites within 50 mi
  3. This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

    NCT07028853

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest sites: University Hospitals Cleveland Medical Center (Cleveland, OH); UH Minoff Health Center at Chagrin Highlands (Orange, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  4. FOG-001 in Locally Advanced or Metastatic Solid Tumors

    NCT05919264

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Cleveland Clinic (Cleveland, OH); University Hospitals Cleveland Medical Center, Seidman Cancer Center (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  5. International Registry for Men With Advanced Prostate Cancer (IRONMAN)

    NCT03151629

    • Observational
    • Ages 21 years and older
    • Sex: Male

    Nearest site: University Hospitals Cleveland Medical Center (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  6. Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

    NCT03678025

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest site: MetroHealth Medical Center (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  7. The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

    NCT04585750

    • Phase 1/2
    • Ages 12 years and older
    • Sex: All

    Nearest site: The Cleveland Clinic Taussig Cancer Center (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  8. Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer

    NCT04787744

    • Phase 2/3
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Louis Stokes VA Medical Center, Cleveland, OH (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  9. Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

    NCT05176483

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Exelixis Clinical Site #10 (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  10. cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

    NCT05366881

    • Observational
    • Ages 40 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Cleveland Clinic (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  11. Cleveland African American Prostate Cancer Project

    NCT05469269

    • Interventional
    • Ages 40 years and older
    • Sex: Male
    • Accepts healthy volunteers

    Nearest site: Barbershops Local to Cleveland (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  12. Metabolic Impact of Prospective Controlled Mediterranean Type Diets on Prostate Cancer

    NCT05590624

    • Interventional
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Case Comprehensive Cancer Center, Cleveland Clinic Foundation (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  13. Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound

    NCT05610852

    • Interventional
    • Ages 19 years and older
    • Sex: Male

    Nearest site: Glickman Urological & Kidney Institute, Cleveland Clinic Foundation, Case Comprehensive Cancer Center (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  14. Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer

    NCT05803941

    • Phase 4
    • Ages 18 to 100 years
    • Sex: Male

    Nearest site: Cleveland Clinic Foundation (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  15. A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors

    NCT05932862

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Exelixis Clinical Site #7 (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  16. Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr

    NCT05948657

    • Interventional
    • Ages 18 years and older
    • Sex: Male

    Nearest site: UH Cleveland Medical Center (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  17. Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)

    NCT06136624

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: University Hospitals Cleveland Medical Center ( Site 0043) (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  18. A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

    NCT06136650

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest site: University Hospitals Cleveland Medical Center ( Site 0043) (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

    NCT06150417

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University Hospitals Cleveland Medical Center Seidman Cancer Center (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)

    NCT06353386

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University Hospitals Cleveland Medical Center ( Site 0043) (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

    NCT06465069

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University Hospitals Cleveland Medical Center (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. Study With [225Ac]Ac-FL-020 in mCRPC Participants

    NCT06492122

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University Hospital of Cleveland (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial

    NCT06496256

    • Interventional
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University Hospitals Cleveland Medical Center (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. Sacral Neuromodulation for Male Overactive Bladder (MOAB)

    NCT06511141

    • Interventional
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University Hospitals Cleveland (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC)

    NCT06549465

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: The Cleveland Clinic Foundation (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. STereotActic Body Radiotherapy and 177Lutetium PSMA in Locally Advanced Prostate Cancer

    NCT06574880

    • Phase 1/2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University Hospitals Cleveland Medical Center Seidman Cancer Center, Case Comprehensive Cancer Center (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

    NCT06632977

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: MetroHealth Medical Center (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer

    NCT06738303

    • Phase 2
    • Ages 19 years and older
    • Sex: All

    Nearest site: Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center Seidman Cancer Center, Cleveland Clinic Taussig Cancer Center (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

    NCT06842498

    • Phase 2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University Hospitals Cleveland Medical Center (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. Study of DCC-2812 in Participants With Advanced Genitourinary Cancers

    NCT06966024

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Cleveland Clinic (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  31. The Vanguard Study: Testing a New Way to Screen for Cancer

    NCT06995898

    • Interventional
    • Ages 45 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Louis Stokes Cleveland VA Medical Center (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  32. A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer

    NCT07082920

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University Hospitals Cleveland Medical Center (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  33. Investigation of Impact of AI on Prostate Cancer Workflow

    NCT07084779

    • Interventional
    • Ages 55 to 80 years
    • Sex: All

    Nearest site: Cleveland Clinic Foundation (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  34. Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

    NCT07140900

    • Phase 1
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Cleveland Clinic Foundation (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  35. A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

    NCT07164443

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest site: University Hospital of Cleveland (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  36. Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

    NCT07200830

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest site: MetroHealth Medical Center (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  37. An Open-label Dose Escalation and Expansion, Followed by a Phase II Study of Tulmimetostat (DZR123) and JSB462 (Luxdegalutamide) in Patients With Progressive Metastatic Castrate Resistant Prostate Cancer (mCRPC) (TulmiSTAR-01)

    NCT07206056

    • Phase 1/2
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Cleveland Clinic Foundation (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  38. A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer

    NCT07319871

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University Hospitals Cleveland Medical Center (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  39. A Study to Learn About Real-world Utilization and Outcomes of Darolutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) for Newly Diagnosed Metastatic Hormone-sensitive Prostate Cancer (de Novo mHSPC) in US Urology Clinics

    NCT07406282

    • Observational
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Precision Point Specialty LLC PPS Analytics, a Specialty Networks LLC Company (Cleveland, OH)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  40. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    NCT03452774

    • Observational
    • Ages Any age
    • Sex: All

    Nearest site: Massive Bio SYNERGY-AI site (Mayfield Heights, OH)

    Distance to nearest recruiting site
    ~12 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  41. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    NCT05334069

    • Observational
    • Ages 40 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: Summa Health Medina Medical Center (Medina, OH); Cleveland Clinic Akron General (Akron, OH)

    Distance to nearest recruiting site
    ~26 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  42. Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body

    NCT06470243

    • Phase 3
    • Ages 18 years and older
    • Sex: Male

    Nearest site: Saint Joseph Warren Hospital (Warren, OH)

    Distance to nearest recruiting site
    ~49 mi (city-level)
    Recruiting sites
    1 site within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Prostate Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.